These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12164547)

  • 21. Role of the Nrf2-ARE pathway in acrylamide neurotoxicity.
    Zhang L; Gavin T; Barber DS; LoPachin RM
    Toxicol Lett; 2011 Aug; 205(1):1-7. PubMed ID: 21540084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acrylamide-induced nerve terminal damage: relevance to neurotoxic and neurodegenerative mechanisms.
    Lopachin RM; Gavin T
    J Agric Food Chem; 2008 Aug; 56(15):5994-6003. PubMed ID: 18624437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies.
    Spencer PS; Schaumburg HH
    J Neuropathol Exp Neurol; 1977; 36(2):300-20. PubMed ID: 190358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of subchronic exposure to acrylamide induced on the expression of bcl-2, bax and caspase-3 in the rat nervous system.
    Li SX; Cui N; Zhang CL; Zhao XL; Yu SF; Xie KQ
    Toxicology; 2006 Jan; 217(1):46-53. PubMed ID: 16242231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurological evaluation of toxic axonopathies in rats: acrylamide and 2,5-hexanedione.
    LoPachin RM; Ross JF; Reid ML; Das S; Mansukhani S; Lehning EJ
    Neurotoxicology; 2002 May; 23(1):95-110. PubMed ID: 12164553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in Na-K ATPase and protein kinase C activities in peripheral nerve of acrylamide-treated rats.
    Lehning EJ; LoPachin RM; Mathew J; Eichberg J
    J Toxicol Environ Health; 1994 Jul; 42(3):331-42. PubMed ID: 8021966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of the toxicology of acrylamide.
    Exon JH
    J Toxicol Environ Health B Crit Rev; 2006; 9(5):397-412. PubMed ID: 17492525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acrylamide-induced changes in the neurofilament protein of rat cerebrum fractions.
    Yu S; Zhao X; Zhang T; Yu L; Li S; Cui N; Han X; Zhu Z; Xie K
    Neurochem Res; 2005 Sep; 30(9):1079-85. PubMed ID: 16292499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relevance of axonal swellings and atrophy to gamma-diketone neurotoxicity: a forum position paper.
    LoPachin RM; Lehning EJ
    Neurotoxicology; 1997; 18(1):7-22. PubMed ID: 9215980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mechanism of acrylamide neurotoxicity: lessons learned from organic chemistry.
    LoPachin RM; Gavin T
    Environ Health Perspect; 2012 Dec; 120(12):1650-7. PubMed ID: 23060388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. gamma-Diketone neuropathy: axon atrophy and the role of cytoskeletal protein adduction.
    LoPachin RM; DeCaprio AP
    Toxicol Appl Pharmacol; 2004 Aug; 199(1):20-34. PubMed ID: 15289087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-toxicity analysis of type-2 alkenes: in vitro neurotoxicity.
    Lopachin RM; Barber DS; Geohagen BC; Gavin T; He D; Das S
    Toxicol Sci; 2007 Jan; 95(1):136-46. PubMed ID: 17023561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rate of neurotoxicant exposure determines morphologic manifestations of distal axonopathy.
    LoPachin RM; Lehning EJ; Opanashuk LA; Jortner BS
    Toxicol Appl Pharmacol; 2000 Sep; 167(2):75-86. PubMed ID: 10964758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gbetagamma acts at the C terminus of SNAP-25 to mediate presynaptic inhibition.
    Gerachshenko T; Blackmer T; Yoon EJ; Bartleson C; Hamm HE; Alford S
    Nat Neurosci; 2005 May; 8(5):597-605. PubMed ID: 15834421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of calcium entry during axon injury and degeneration.
    LoPachin RM; Lehning EJ
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):233-44. PubMed ID: 9144441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inulin supplementation during gestation mitigates acrylamide-induced maternal and fetal brain oxidative dysfunctions and neurotoxicity in rats.
    Krishna G; Muralidhara
    Neurotoxicol Teratol; 2015; 49():49-58. PubMed ID: 25801384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. III. Recovery from single injections and multiple dosing effects of acrylamide and 2,5-hexanedione.
    Sickles DW
    Toxicol Appl Pharmacol; 1991 May; 108(3):390-6. PubMed ID: 2020966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acrylamide disrupts elemental composition and water content of rat tibial nerve. III. Recovery.
    LoPachin RM; Lehning EJ; Castiglia CM; Saubermann AJ
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):54-60. PubMed ID: 8378932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acrylamide disrupts elemental composition and water content of rat tibial nerve. II. Schwann cells and myelin.
    LoPachin RM; Castiglia CM; Saubermann AJ
    Toxicol Appl Pharmacol; 1992 Jul; 115(1):35-43. PubMed ID: 1631891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acrylamide disrupts elemental composition and water content of rat tibial nerve. I. Myelinated axons.
    LoPachin RM; Castiglia CM; Saubermann AJ
    Toxicol Appl Pharmacol; 1992 Jul; 115(1):21-34. PubMed ID: 1631890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.